BARDA Funding for Next-Generation Therapeutics and Vaccines for COVID-19 available through Rapid Response Partnership Vehicle (RRPV) - EverGlade Consulting

BARDA Funding for Next-Generation Therapeutics and Vaccines for COVID-19 available through Rapid Response Partnership Vehicle (RRPV)

EverGlade and BARDA funding

The Rapid Response Partnership Vehicle (RRPV) Consortium is a joint initiative with the Biomedical Research and Development Authority (BARDA) to promote research and development in response to pandemics or public health emergencies. 

Scroll to Top